158 related articles for article (PubMed ID: 31757742)
1. β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells.
Mikami D; Kobayashi M; Uwada J; Yazawa T; Kamiyama K; Nishimori K; Nishikawa Y; Nishikawa S; Yokoi S; Taniguchi T; Iwano M
J Pharmacol Sci; 2020 Jan; 142(1):1-8. PubMed ID: 31757742
[TBL] [Abstract][Full Text] [Related]
2. β-Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells.
Mikami D; Kobayashi M; Uwada J; Yazawa T; Kamiyama K; Nishimori K; Nishikawa Y; Morikawa Y; Yokoi S; Takahashi N; Kasuno K; Taniguchi T; Iwano M
Life Sci; 2019 Apr; 222():125-132. PubMed ID: 30851335
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.
Lau CK; Yang ZF; Lam SP; Lam CT; Ngai P; Tam KH; Poon RT; Fan ST
Cancer Biol Ther; 2007 Dec; 6(12):1900-7. PubMed ID: 18059167
[TBL] [Abstract][Full Text] [Related]
4. Survivin depletion inhibits tumor growth and enhances chemosensitivity in hepatocellular carcinoma.
Or YY; Chow AK; Ng L; Fan ST; Yau TC; Poon RT; Pang RW
Mol Med Rep; 2014 Oct; 10(4):2025-30. PubMed ID: 25070628
[TBL] [Abstract][Full Text] [Related]
5. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
[TBL] [Abstract][Full Text] [Related]
6. PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.
Huang SH; Xiong M; Chen XP; Xiao ZY; Zhao YF; Huang ZY
Oncol Rep; 2008 Sep; 20(3):567-72. PubMed ID: 18695907
[TBL] [Abstract][Full Text] [Related]
7. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
8. Ketone bodies as signaling metabolites.
Newman JC; Verdin E
Trends Endocrinol Metab; 2014 Jan; 25(1):42-52. PubMed ID: 24140022
[TBL] [Abstract][Full Text] [Related]
9. The Ketone Metabolite β-Hydroxybutyrate Attenuates Oxidative Stress in Spinal Cord Injury by Suppression of Class I Histone Deacetylases.
Kong G; Huang Z; Ji W; Wang X; Liu J; Wu X; Huang Z; Li R; Zhu Q
J Neurotrauma; 2017 Sep; 34(18):2645-2655. PubMed ID: 28683591
[TBL] [Abstract][Full Text] [Related]
10. Synergy of Raddeanin A and cisplatin induced therapeutic effect enhancement in human hepatocellular carcinoma.
Li JN; Yu Y; Zhang YF; Li ZM; Cai GZ; Gong JY
Biochem Biophys Res Commun; 2017 Apr; 485(2):335-341. PubMed ID: 28219642
[TBL] [Abstract][Full Text] [Related]
11. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
13. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
14. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.
Shimazu T; Hirschey MD; Newman J; He W; Shirakawa K; Le Moan N; Grueter CA; Lim H; Saunders LR; Stevens RD; Newgard CB; Farese RV; de Cabo R; Ulrich S; Akassoglou K; Verdin E
Science; 2013 Jan; 339(6116):211-4. PubMed ID: 23223453
[TBL] [Abstract][Full Text] [Related]
15. [Matrine enhances the anticancer effect of cisplatin against hepatocellular carcinoma xenografts in nude mice by influencing expression of survivin/caspase-3].
Hu G; Huang Z; Zhou X; Hu J; Huang B
Zhonghua Gan Zang Bing Za Zhi; 2015 Sep; 23(9):669-74. PubMed ID: 26524360
[TBL] [Abstract][Full Text] [Related]
16. Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma.
Srinivas C; Swathi V; Priyanka C; Anjana Devi T; Subba Reddy BV; Janaki Ramaiah M; Bhadra U; Bhadra MP
Apoptosis; 2016 Nov; 21(11):1249-1264. PubMed ID: 27502208
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma.
Tam KH; Yang ZF; Lau CK; Lam CT; Pang RW; Poon RT
Cancer Lett; 2009 Jan; 273(2):201-9. PubMed ID: 18824293
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2.
Qu X; Gao H; Zhai J; Sun J; Tao L; Zhang Y; Song Y; Hu T
Eur J Pharm Sci; 2020 May; 148():105325. PubMed ID: 32259679
[TBL] [Abstract][Full Text] [Related]
19. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition.
Zhang M; Pan Y; Dorfman RG; Chen Z; Liu F; Zhou Q; Huang S; Zhang J; Yang D; Liu J
Oncotarget; 2016 Apr; 7(16):22285-94. PubMed ID: 26993777
[TBL] [Abstract][Full Text] [Related]
20. Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.
Bandolik JJ; Hamacher A; Schrenk C; Weishaupt R; Kassack MU
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
